Neurotoxins of Clostridium botulinum are needed in basic neurologic research, but as therapeutic agent for certain neuromuscular disorders like strabism as well. A method for the production and purification of botulinum neurotoxins C and D is reported using a two-step hollow-fiber cross flow filtration and a newly developed chromatographic purification procedure. Hollow-fiber filtration proved to be a rapid and safe concentration and pre-purification step, which can easily be scaled up. The chromatographic purification included hydrophobic interaction, anion exchange and size exclusion chromatography runs. Botulinum neurotoxins C and D could be recovered with an overall yield of 12.6% and 10.6%, respectively. A specific toxicity of 1.86U10 7 minimal lethal dose mg 31 (type C) and 5.26U10 7 minimal lethal dose mg 31 (type D) was determined in the mouse bioassay. ß
Introduction
Botulinum neurotoxins (BoNT), which are produced by Clostridium botulinum, an anaerobic spore former, belong to the most toxic biological substances. For more than a century, research focused on the structure and pathogenesis of the seven distinct neurotoxins (A^G) and the associated diseases. Types A, B and E are generally considered as being pathogenic for humans, types C and D are often isolated in cases of animal botulism.
One of the ¢rst reports on botulism was written by Justinus Kerner, a German physician and poet. But he did not only increase our basic knowledge on the disease and the causative agent. As early as 1822, he already discussed the possible therapeutic use of BoNT or the`fatty acid' as he called it [1] . However, it lasted 160 years until the bene¢ts of BoNT were discovered and investigated again [2] . Since then, BoNT has become an important agent in treating strabism, blepharospasm, dystonia and other, similar diseases, caused by neuro-muscular disorders [3] . This, on the other hand, increased the demand for puri¢ed BoNT, which is also needed in basic neurologic research, e.g. transmitter release studies [4] .
Previously published puri¢cation procedures for BoNT usually include an initial precipitation [5, 6] or at least a centrifugation step [7] . Due to the high toxicity of BoNT, this puri¢cation is di¤cult and/or hazardous to run with larger volumes of cul-ture broth. Based on previous experiences with hollow-¢ber cross £ow ¢ltration [8] , we have attempted to develop an initial, self-contained two-step ¢ltra-tion, which separates the metabolites including the toxin from the bacteria and the low molecular weight substances, e.g. the media peptides. The concentrate was subject to a newly developed chromatographic puri¢cation procedure to obtain highly puri¢ed BoNT/C and D, which were intended to be used for antibody production.
Material and methods

Bacterial strains
C. botulinum type C IBT 2300 and type D IBT 2301 (kindly donated by S. Kozaki, Osaka Prefecture University, Japan) were used in this study.
Protein electrophoresis
Fermentor and chromatography samples were routinely separated electrophoretically by SDS-PAGE using a 7.5% separating and 2% stacking gel. For reducing conditions, the sample was diluted 1:2 with sample bu¡er, which was supplemented with DTT (30 mg ml 31 ) and incubated in a water bath (100³C, 3 min). The separation was run at a constant voltage of 200 V.
Gels were silver-stained according to Heukeshoven and Dernick [9] , scanned and analyzed with RFLPscan (Scanalytics).
Mouse bioassay
The biological activity of BoNT/C and BoNT/D was measured in NMRI mice weighing 18^25 g. To reduce the number of animals needed in this study, 0.5 ml of serial 10-fold dilutions of the samples were injected intraperitoneal into two mice per dilution only and the animals were observed for clinical signs or death over a period of 3 days. In addition samples of the fermentor, harvests and the puri¢ed toxins were diluted 2-fold in between the positive and negative 10-fold dilutions. The minimal lethal dose (MLD) describes the reciprocal value of the highest dilution at which both mice died.
Hemagglutinin assay
The hemagglutinating activity of harvest and chromatographic fractions was quanti¢ed in a microtiter plate assay. Serial 2-fold dilutions of the samples were made in 20 mM Tris-HCl, pH 7.2, 150 mM NaCl using 96-well microtiter plates (U-shaped). An equal volume of 1% human red blood cell suspension in the dilution bu¡er was added. Plates were incubated at room temperature overnight. The hemagglutination titer corresponds to the reciprocal value of the highest dilution at which agglutination of the cells could be observed.
Toxin production
Inoculum of both strains was prepared in 100-ml £asks. The strains were incubated overnight in 50 ml cooked meat medium (Difco) at 37³C. The £asks were placed in an anaerobic jar. A suitable atmosphere, which initially consisted of 90% N 2 , 5% H 2 and 5% CO 2 , was generated with the gas supplying system Anoxomat (Mart).
For toxin production, the`Go « ttinger Bioreactor' was used with slight modi¢cations as previously reported [10] . Brie£y, a 20 l fermentor vessel containing 10 l medium, which consisted of 1% peptone from casein, pancreatically digested, 1% meat extract, 0.3% yeast extract, 0.1% soluble starch, 0.5% D-glucose, 0.5% sodium chloride, 0.3% sodium acetate and 0.05% L-cysteine-HCl, was inoculated with the overnight culture of type C or D, respectively. Medium for type C was supplemented with 3% cooked meat (Difco). Initially, the pH was adjusted to 6.8. The fermentor culture was incubated for 4 days at 37³C with a continuous N 2 over£ow. Every day, samples where taken, checked for contamination and examined in SDS-PAGE.
For the two following batches of each strain, no inoculum was prepared. 10 l of new medium was added to approximately 300 ml culture, left over from the previous cultivation.
Toxin ¢ltration and chromatographic puri¢cation
In general, type C and D toxin were puri¢ed according to the same procedure. The ¢ltration and further puri¢cation steps of the toxins are summarized in Fig. 1 .
Within a self-contained system, the cultures were harvested and ¢ltered using a hollow-¢ber cartridge, which retains molecules s 1 mio D (SPS 9005-8B/4, Fresenius). The ¢ltrate of this step was applied to a cartridge with a 30-kDa cut-o¡ (SPS 6005-8B/4). During ¢ltration, bu¡er was exchanged to 50 mM Tris-HCl, pH 8.0, 1.0 M ammonium sulfate.
The retained suspension of the second ¢ltration step was subject to chromatographic puri¢cation, which was run on an A ë kta system (Amersham Pharmacia). Column hardware and resins were supplied by Amersham Pharmacia if nothing else is stated. All fractions collected during the chromatophic runs were analyzed by SDS-PAGE. If a presumptive toxin band could be detected electrophoretically within a peak, the fraction was checked for the presence of toxin in the mouse bioassay, but only the puri¢ed toxin was quanti¢ed.
For hydrophobic interaction chromatography, the concentrated supernatant was applied to a phenylsepharose HP column, equilibrated with 50 mM Tris-HCl, pH 8.0, 1.0 M ammonium sulfate. The toxin was eluted with a linear gradient from 1.0 to 0.0 M ammonium sulfate in the same bu¡er. The fractions in which toxin was detected were pooled and dialyzed against 50 mM Tris-HCl, pH 8.0, for 48 h.
The dialyzed fractions were further puri¢ed on an anion exchange column, which was packed with Source 30 Q. The column was equilibrated with 50 mM Tris-HCl, pH 8.0, and fractions were eluted with an increasing NaCl gradient from 0.0 to 0.24 M in the same bu¡er. Again, the fractions were checked for the presence of toxin and the positive fractions pooled and dialyzed against 50 mM Bis-Tris, pH 6.0, for 48 h.
The next step was the application of the pool to a Source 15 Q column, pre-equilibrated with the dialyzing bu¡er. Elution was run with a linear gradient of 0.0^0.14 M NaCl in the same bu¡er. For the ¢nal polishing, the pooled toxin fractions were applied to 
Purity control
The purity of the chromatographed toxin was assessed in SDS-PAGE with and without DTT treatment and on an analytical anion exchange column.
For the analytical anion exchange chromatography on a MonoQ column, 1 ml of the toxin solution was diluted 10-fold to decrease the NaCl concentration. The same bu¡ers with pH 8.0 for equilibration and elution were used as in the anion exchange chromatography step with Souce 30 Q during toxin puri¢cation.
Protein measurement
Protein concentrations of the fermentor harvest, the ¢ltrated cultures and the puri¢ed toxin were measured with a commercially available assay (BCA Protein Assay, Pierce).
Results
Toxin production
During the three consecutive batches, an average amount of 4.0U10 8 
Toxin ¢ltration and chromatographic puri¢cation
The results of the puri¢cation steps of BoNT/C and D are summarized in Table 1 . The data given represent the average values of the three consecutive batches run with each strain. During the hollow-¢ber ¢ltration, the cultures could be concentrated more than 10-fold. Fig. 2 shows this e¡ect on the high molecular weight metabolites including the neurotoxins in SDS-PAGE. The protein concentration was reduced to at least 10% of the amount measured in the untreated fermentor broth. Fig. 3 gives representative chromatograms obtained during the four puri¢cation steps. In hydrophobic interaction chromatography, no toxin was detected in the fractions containing the unbound proteins. The toxin started to elute at an ammonium sulfate concentration of 190 mM. However, separation of the hemagglutinin could only partially be achieved, although alkaline conditions (pH 8.0) were applied. In the following anion exchange chromatography at pH 8.0, neurotoxin and hemagglutinin eluted in separate peaks. At pH 6.0, the next step, BoNT eluted in one distinct peak. No hemagglutinin activity could be detected within any fraction. During ¢nal polishing on Superdex 200, only one homogeneous peak eluted, containing the neurotoxin.
According to the mouse bioassay, an average over- A high purity of the toxins was proven with the use of the MonoQ column. All the protein present in the sample bound to the column and eluted in one distinct peak.
The separation of the puri¢ed neurotoxins in SDS-PAGE is shown for type D in Fig. 4 . Both toxins banded at V144 kDa, if no reducing conditions were applied. With DTT treatment, two distinct bands were found at V98 kDa and V49 kDa. No impurities could be detected electrophoretically.
Discussion
Several reports on the puri¢cation of BoNT/C and BoNT/D have been published. The puri¢cation usually starts with an ammonium sulfate [5] or an acid precipitation [6] . This step is time consuming, since precipitating and resuspending takes 1^2 days. De Jongh et al. [7] already used hollow-¢ber ¢ltration for the concentration of the culture supernatant of BoNT/D. However, they centrifuged the bacterial culture prior to the ¢ltration to separate bacteria and supernatant. But centrifugation is di¤cult to perform with larger amounts of fermentor culture, especially with high toxic material like C. botulinum. With an initial two-step hollow-¢ber ¢ltration, the culture supernatant can be separated from the cells, concentrated and partially puri¢ed. The volume, which can be ¢ltered, depends mainly on the ¢lter cartridges used. With larger cartridges or several cartridges, which are run parallel, this process can easily be scaled up to industrial needs. Since the culture can be transferred to the ¢ltration unit within a self-contained system, the risk of contamination and aerosol formation can be minimized. In addition, bu¡er can be exchanged to the sample bu¡er needed in the ¢rst chromatographic step. Thus, the ¢ltration o¡ers a convenient, quick and safe procedure to prepare the culture for the following chromatographic puri¢cation.
Hydrophobic interaction chromatography was used as the ¢rst step in further puri¢cation. According to unpublished results, obtained in our lab, this technique was superior to initial ion exchange chromatography, which was used in previous reports on toxin puri¢cation [7] . However, total separation of neurotoxin and hemagglutinin could only be achieved in the second step on an anion exchange column. Depending on the intended use of the puri¢ed toxins, ¢nal polishing in size exclusion chromatography might be omitted. In the last anion exchange step, the toxin already eluted in one distinct peak.
In SDS-PAGE, samples of the puri¢ed preparations banded at V144 kDa only. With DTT treatment, the toxin molecules were cleaved into the heavy and the light chain, banding at V98 kDa and V49 kDa, respectively, supporting previous data on the molecular weight of these toxins [7, 11, 12] .
The puri¢ed toxins had a speci¢c toxicity of 1.86U10 7 MLD mg 31 (BoNT/C) and 5.26U10 7 MLD mg 31 (BoNT/D). Moriishi et al. [11] reported that they were able to increase the toxicity of a puri¢ed BoNT/D toxin (D-SA) by trypsin treatment. Trypsinization of the puri¢ed BoNT/C and D obtained in this study resulted in a total loss of the neurotoxic activity in the mouse bioassay (data not published). This might provide further evidence for the theory of molecular diversity within the tertiary structure of type D strains [11] . However, it cannot be ruled out that the toxins, puri¢ed according to the presented procedure, are totally separated from any protecting proteins, thus being highly susceptible to proteolytic cleavage.
